- The Indian government has proposed tighter curbs on the advertising of prescription drugs to prevent misleading claims and protect public health. - The regulatory initiative seeks to plug loopholes in existing laws like the Drugs and Cosmetics Act and the Drugs and Magic Remedies Act. - Unchecked advertising of prescription pharmaceuticals can lead to self-medication, health hazards, and unethical marketing practices by pharmaceutical companies. - Strengthening enforcement mechanisms and penal provisions is crucial to curb misleading medical advertisements targeting vulnerable consumers. - **Drugs and Cosmetics Act:** An Indian legislation regulating the import, manufacture, distribution, and sale of drugs and cosmetics. Under the Drugs Rules, it restricts the advertising of prescription-only drugs to protect public health. - **Drugs and Magic Remedies (Objectionable Advertisements) Act:** A central statute prohibiting misleading advertisements for drugs and magical remedies that claim to cure specific diseases, aiming to combat quackery and consumer deception. - **Drugs Technical Advisory Board (DTAB):** A statutory advisory body constituted under the Drugs and Cosmetics Act to advise the Central and State Governments on technical matters related to drug standards and regulation. - **Ministry of Health and Family Welfare:** The nodal central government department responsible for formulating health policies, administering public health laws, and overseeing pharmaceutical regulation and consumer health protection in India. **Introduction** The Union government has proposed stricter regulations on advertising prescription drugs to curb misleading claims, combat self-medication, and ensure consumer protection in the healthcare sector. **Core Issue and Detailed Points** - The Indian government has proposed tighter curbs on the advertising of prescription drugs to prevent misleading claims and protect public health. - The regulatory initiative seeks to plug loopholes in existing laws like the Drugs and Cosmetics Act and the Drugs and Magic Remedies Act. - Unchecked advertising of prescription pharmaceuticals can lead to self-medication, health hazards, and unethical marketing practices by pharmaceutical companies. - Strengthening enforcement mechanisms and penal provisions is crucial to curb misleading medical advertisements targeting vulnerable consumers. **Key Statutory Bodies, Acts & Concepts** - **Drugs and Cosmetics Act:** An Indian legislation regulating the import, manufacture, distribution, and sale of drugs and cosmetics. Under the Drugs Rules, it restricts the advertising of prescription-only drugs to protect public health. - **Drugs and Magic Remedies (Objectionable Advertisements) Act:** A central statute prohibiting misleading advertisements for drugs and magical remedies that claim to cure specific diseases, aiming to combat quackery and consumer deception. - **Drugs Technical Advisory Board (DTAB):** A statutory advisory body constituted under the Drugs and Cosmetics Act to advise the Central and State Governments on technical matters related to drug standards and regulation. - **Ministry of Health and Family Welfare:** The nodal central government department responsible for formulating health policies, administering public health laws, and overseeing pharmaceutical regulation and consumer health protection in India.